Note 6 Segment reporting


The division into business areas reflects AddLife’s internal organisation and reporting system. Operating segments are reported in a manner consistent with AddLife's internal reporting, which is submitted to the CEO, who has been identified as the highest executive within AddLife. AddLife reports business areas as an operating segment. AddLife reports its business areas as operating segments. The two business areas are Labtech and Medtech. This market grouping reflects a natural division of the Life Science market. AddLife uses EBITA (see definitions) as a performance measure when monitoring the business areas. Intra-Group sales are based on the same prices that an independent party would pay for the product.

Labtech

The companies in the Labtech business area operate within diagnostics and biomedical research, as well as laboratory analysis. The companies deliver directly to customers various products and solutions that include analytical instruments, equipment, microscopes, consumables and reagents, as well as software support and technical service, primarily to laboratories in medicine, research, academia and the food and pharmaceutical industries. The companies within the Labtech business area are mainly active in microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, point-of-care testing, veterinary diagnostics and in the food industry. Customers are also offered training programmes in various areas to ensure that customers have the appropriate skills and to maximise user benefit for the products the Company provides.

Medtech

The companies in the Medtech business area provide medical device products within the medtech market, with a focus on surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. 

Data by operating segment

Download Excel

      2022 2021
Net sales     Externally Externally
Medtech     5,210 3,625
Labtech     3,880 4,373
Group items     -6 -5
Total     9,084 7,993
         
  2022 2021
EBITA EBITA EBITA
margin, %
EBITA EBITA
margin, %
Medtech 573 11.0 310 8.6
Labtech 667 17.2 977 22.3
Group items -19   -14  
Total 1,221   1,273  

Download Excel

  2022 2021
Operating profit/loss, assets and liabilities Operating profit Assets¹ Liabilities¹ Operating profit Assets¹ Liabilities¹
Medtech 228 10,231 1,416 85 8,127 941
Labtech 601 2,312 887 927 2,090 838
Group items -21 514 5,783 -16 379 4,526
Total 808 13,057 8,086 996 10,596 6,305
Finance income and costs -206     -69    
Profit before taxes 602     927    
¹ Does not include balances in Group accounts or financial transactions with Group companies.

Download Excel

  2022 2021
Investments in non-current assets Intangible Property, plant and equipment¹ Total Intangible Property, plant and equipment¹ Total
Medtech 517 242 759 1,826 234 2,060
Labtech 127 108 235 133 96 229
Group items 0 0 0 0 0 0
Total 644 350 994 1,959 330 2,289
¹ The amounts do not include the effects of corporate acquisitions.
             
  2022 2021
Depreciation/amortisation of non-current assets Intangible Property, plant and equipment¹ Total Intangible Property, plant and equipment¹ Total
Medtech -345 -199 -544 -225 -102 -327
Labtech -66 -107 -173 -50 -97 -147
Group items -2 -3 -5 -2 -3 -5
Total -413 -309 -722 -277 -202 -479
¹ Depreciation/amortisation of property, plant and equipment include depreciation/amortisation of right- of-use assets.

Download Excel

Significant profit or loss items, other than depreciation or amortisation, not matched by payments
  2022 2021
  Capital gains Change in pension liability Other items Total Capital gains Change in pension liability Other items Total
Medtech 1 -2 -118 -119 -2 -1 0 -3
Labtech -3 -2 -22 -27 -1 -1 -6 -8
Group items 105 105 -22 -22
Total -2 -4 -35 -41 -3 -2 -28 -33

Download Excel

  2022 2021
Data by country Net sales external Assets¹ Of which non-current assets Net sales external Assets¹ Of which non-current assets
Sweden 1,100 1,590 1,116 1,141 1,465 1,081
Denmark 956 650 405 1,158 682 398
Finland 582 299 129 648 260 131
Norway 876 515 292 1,009 484 280
Ireland 892 3,580 3,200 582 3,273 2,959
Spain 725 1,339 835
UK 980 385 83 620 340 58
Germany 357 2,454 2,321 480 2,119 2,020
Other countries 2,616 1,895 951 2,355 1,885 891
Group items and unallocated assets 350 153 88 27
Total 9,084 13,057 9,485 7,993 10,596 7,845
¹ Does not include balances in Group accounts and financial assets. External net sales are based on the customers' location, and the carrying amounts of assets are based on where the assets are located.
             
  2022 2021
Investments in non-current assets Intangible Property, plant and equipment Total Intangible Property, plant and equipment Total
Sweden 100 40 140 46 21 67
Denmark 1 16 17 82 11 93
Finland 0 7 7 3 22 25
Norway 10 42 52 7 16 23
Ireland 31 23 54 876 110 986
Spain 406 68 474
UK 3 51 54 0 64 64
Germany 85 9 94 823 13 836
Other countries 8 94 102 122 73 195
Total 644 350 994 1,959 330 2,289
The Group has no single customer whose revenues account for 10 percent of total revenue, for which reason there is no related reporting.